These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Response by Solomon to Letter Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study". Solomon SD Circulation; 2019 Jul; 140(2):e92-e93. PubMed ID: 31283371 [No Abstract] [Full Text] [Related]
3. Letter by González-Costello et al Regarding Article, "Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-mediated Amyloidosis: Analysis of the APOLLO Study". González-Costello J; Casasnovas C; Díez-López C Circulation; 2019 Jul; 140(2):e90-e91. PubMed ID: 31283374 [No Abstract] [Full Text] [Related]
4. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met). Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348 [No Abstract] [Full Text] [Related]
5. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review. Yin J; Xia X; Shi Y; Lu Y; Zhao C; Huang Z; Tian N Amyloid; 2014 Jun; 21(2):140-2. PubMed ID: 24601824 [No Abstract] [Full Text] [Related]
6. RNA Interference and Neuromuscular Diseases: A Focus on Hereditary Transthyretin Amyloidosis. Ceccanti M; Inghilleri M Curr Gene Ther; 2024; 24(1):6-7. PubMed ID: 37710997 [TBL] [Abstract][Full Text] [Related]
7. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg. Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332 [No Abstract] [Full Text] [Related]
8. A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation. Matsumoto S; Ueda M; Yamashita T; Amano T; Misumi Y; Tasaki M; Masuda T; Mizukami M; Furuya H; Ando Y Amyloid; 2017 Mar; 24(sup1):97-98. PubMed ID: 28434367 [No Abstract] [Full Text] [Related]
9. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan. Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687 [TBL] [Abstract][Full Text] [Related]
10. Transthyretin-related hereditary amyloidosis in an Argentinian family with TTR Tyr114Cys mutation. Aguirre MA; Nucifora EM; Rugiero M; Sorroche P; Saez MS; Giunta DH; Posadas-Martinez ML; Boietti BR Amyloid; 2017 Mar; 24(sup1):102. PubMed ID: 28434328 [No Abstract] [Full Text] [Related]
11. Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis. Yang J Expert Rev Clin Pharmacol; 2019 Feb; 12(2):95-99. PubMed ID: 30644768 [TBL] [Abstract][Full Text] [Related]
12. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation. Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309 [TBL] [Abstract][Full Text] [Related]
13. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis. Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297 [No Abstract] [Full Text] [Related]
14. First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosis. Hagenacker T; Brenck J; Kastrup O J Neurol Sci; 2014 Nov; 346(1-2):331-2. PubMed ID: 25130926 [No Abstract] [Full Text] [Related]
15. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study. Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346 [No Abstract] [Full Text] [Related]
16. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation. Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341 [No Abstract] [Full Text] [Related]
17. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis. Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071 [TBL] [Abstract][Full Text] [Related]